Bioactive Compounds List
Type Distribution
Max Phase Distribution
Bioactive Compounds List
| Bio ID | Target ID | Target Name | ChEMBL ID | Name | Type | Max Phase | Molecular Weight | Targets | Bioactivities | Molecular Formula | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| bio1641 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2109065 | DROTRECOGIN ALFA (ACTIVATED) | Protein | Phase 4 | -- | -- | -- | -- | Details |
| bio1642 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL4650230 | SIMUFILAM | Small molecule | Phase 3 | 259.35 | -- | -- | C15H21N3O | Details |
| bio1643 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL689 | MANNITOL | Small molecule | Phase 4 | 182.17 | 163.0 | 703.0 | C6H14O6 | Details |
| bio1644 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL1200588 | CLINDAMYCIN HYDROCHLORIDE | Small molecule | Phase 4 | 461.45 | 19.0 | 52.0 | C18H34Cl2N2O5S | Details |
| bio1645 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL558752 | RAF-265 | Small molecule | Phase 2 | 518.42 | 489.0 | 1135.0 | C24H16F6N6O | Details |
| bio1646 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL189475 | LADARIXIN | Small molecule | Phase 3 | 375.35 | 19.0 | 49.0 | C11H12F3NO6S2 | Details |
| bio1647 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2332439 | HEYNEANONES C | Small molecule | -- | 268.35 | 2.0 | 4.0 | C15H24O4 | Details |
| bio1648 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL4297876 | ZALIFRELIMAB | Antibody | Phase 2 | -- | -- | -- | -- | Details |
| bio1649 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2105467 | TEZACITABINE | Small molecule | Phase 2 | 257.22 | -- | -- | C10H12FN3O4 | Details |
| bio1650 | Tar11 | Proto-oncogene c-RAF (c-RAF) | CHEMBL2108795 | MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP C | Oligosaccharide | Phase 3 | -- | -- | -- | -- | Details |